意想不到的慢性淋巴细胞白血病B细胞激活由双酸盐
Andrea N Mazzarello1, Elena Gugiatti1, Vanessa Cossu1
1Department of Experimental Medicine (DIMES), University of Genoa, Via De Toni 14, 16132, Genoa, Italy.
Cancer immunology, immunotherapy : CII
|January 27, 2024
概括
双酸盐 (BPs) 可以在低剂量下意外地促进慢性淋巴细胞白血病 (CLL) 细胞激活和增殖,可能会使预后恶化. 然而,较高剂量对CLL细胞仍然具有细胞毒性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性淋巴细胞白血病 (CLL) 通常影响老年人,经常与骨质疏松症同时发生,需要双酸盐 (BP) 治疗.
- 双酸盐 (BPs) 具有临床前的抗癌特性,这表明在恶性瘤中具有潜在的治疗作用.
研究的目的:
- 为了研究双酸盐 (BPs) 对慢性淋巴细胞白血病 (CLL) B 细胞的体外影响.
- 在模拟微环境模型中探索BP对CLL细胞活力,细胞亡和激活的度依赖作用.
主要方法:
- 通过模仿瘤微环境的刺激激活CLL B细胞的体外研究.
- 评估BP在不同度的影响,包括细胞毒性,亡调节和扩散.
- 研究肌肉细胞和可溶性因子在BP介导的CLL细胞影响中的作用.
主要成果:
- 双酸盐 (BPs) 对CLL B细胞表现出抑制作用.
- 低剂量的BP保护了CLL细胞免受自发和化疗诱导的亡,同时增强了激活和增殖.
- 高剂量的BP在CLL细胞中诱导了细胞毒性.
- 低剂量BPs的促白血病效应依赖于树皮细胞,并涉及可溶性因素和细胞接触.
结论:
- 双酸盐 (BPs) 可以矛盾地促进慢性淋巴细胞白血病 (CLL) 细胞激活和扩散在低度,可能与不良预后标志物相关.
- 这些发现凸显了BP在CLL和骨质疏松症等并发症的背景下对BP的复杂,剂量依赖的影响.
- 需要进一步的研究,以了解这些发现对接受BP治疗的CLL患者的临床影响.
相关概念视频
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Disorders of Leukocytes
955
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
955


